Literature DB >> 23563138

A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients.

Sebastian Kelle, Eike Nagel, Andreas Voss, Nina Hofmann, Gitsios Gitsioudis, Sebastian J Buss, Amedeo Chiribiri, Ernst Wellnhofer, Christoph Klein, Christopher Schneeweis, Christina Egnell, Juliane Vierecke, Alexander Berger, Evangelos Giannitsis, Eckart Fleck, Hugo A Katus, Grigorios Korosoglou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23563138     DOI： 10.1016/j.jacc.2013.02.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  [Cardiac magnetic resonance imaging: from imaging to diagnosis].

Authors:  M Gutberlet
Journal:  Radiologe       Date:  2013-11       Impact factor: 0.635

2.  Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease.

Authors:  Shingo Kato; Naka Saito; Hidekuni Kirigaya; Daiki Gyotoku; Naoki Iinuma; Yuka Kusakawa; Kohei Iguchi; Tatsuya Nakachi; Kazuki Fukui; Masaaki Futaki; Tae Iwasawa; Masataka Taguri; Kazuo Kimura; Satoshi Umemura
Journal:  Heart Vessels       Date:  2015-04-23       Impact factor: 2.037

3.  The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.

Authors:  Mark A Peterzan; Oliver J Rider; Lisa J Anderson
Journal:  Card Fail Rev       Date:  2016-11

4.  Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients.

Authors:  Ravi V Shah; Bobak Heydari; Otavio Coelho-Filho; Siddique A Abbasi; Jiazhuo H Feng; Tomas G Neilan; Sanjeev Francis; Ron Blankstein; Michael Steigner; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2014-04-09

5.  Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.

Authors:  A Doltra; A Skorin; A Hamdan; B Schnackenburg; R Gebker; C Klein; E Nagel; E Fleck; S Kelle
Journal:  Eur Radiol       Date:  2014-05-15       Impact factor: 5.315

Review 6.  Magnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and back.

Authors:  Adelina Doltra; Philipp Stawowy; Thore Dietrich; Christopher Schneeweis; Eckart Fleck; Sebastian Kelle
Journal:  Biomed Res Int       Date:  2013-08-22       Impact factor: 3.411

7.  Incremental cost-effectiveness of dobutamine stress cardiac magnetic resonance imaging in patients at intermediate risk for coronary artery disease.

Authors:  George Petrov; Sebastian Kelle; Eckart Fleck; Ernst Wellnhofer
Journal:  Clin Res Cardiol       Date:  2014-11-14       Impact factor: 5.460

8.  Ischemic burden and clinical outcome: is one 'culprit' ischemic segment by dobutamine stress magnetic resonance predictive?

Authors:  Sorin Giusca; Sebastian Kelle; Eike Nagel; Sebastian Johannes Buss; Valentina Puntmann; Ernst Wellnhofer; Eckart Fleck; Hugo Albert Katus; Grigorios Korosoglou
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

Review 9.  Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification.

Authors:  Grigorios Korosoglou; Sorin Giusca; Gitsios Gitsioudis; Christian Erbel; Hugo A Katus
Journal:  Front Physiol       Date:  2014-08-06       Impact factor: 4.566

Review 10.  Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors:  Marco Francone
Journal:  ISRN Radiol       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.